viewof hfPatients = Inputs.range([100, 5000], {value: 1000, step: 100, label: "Heart failure patients"})
viewof readmissionRate = Inputs.range([15, 35], {value: 25, step: 1, label: "Baseline readmission rate (%)"})
viewof costPerReadmission = Inputs.range([8000, 20000], {value: 13000, step: 500, label: "Cost per readmission ($)"})
viewof nonAdherenceCause = Inputs.range([20, 60], {value: 40, step: 5, label: "Readmissions due to non-adherence (%)"})
viewof bottleCost = Inputs.range([25, 75], {value: 45, step: 5, label: "Smart bottle device cost ($)"})
viewof monthlyConnectivity = Inputs.range([1, 10], {value: 3, step: 1, label: "Monthly connectivity cost ($)"})
viewof baselineAdherenceRate = Inputs.range([50, 80], {value: 65, step: 1, label: "Baseline adherence (%)"})
viewof improvedAdherenceRate = Inputs.range([70, 95], {value: 88, step: 1, label: "Improved adherence (%)"})Heart Failure Readmission ROI
Heart Failure Readmission ROI
animation
healthcare
medication
Try Increase Improved adherence (%) while keeping baseline adherence unchanged. Then press Calculate readmission ROI.
Observe Watch prevented readmissions and ROI year 1 as Improved adherence (%) changes.
Explain Describe how Baseline adherence (%) affects the modeled reduction in nonadherence after you press Calculate readmission ROI.
Technical boundaries. The formula applies relative reduction in nonadherence directly to assumed adherence-related readmissions. This effect requires independent validation; integration and monitoring costs are fixed, and payer reimbursement is separate.
Heart Failure Readmission ROI
Scenario: A health system deploys smart pill bottles for heart failure patients to improve medication adherence and reduce hospital readmissions.
Given:
- Modeled 30-day readmission rate: 25%, close to the 24.5% CMS reported for Medicare heart-failure discharges in 2009; validate against the target cohort. (CMS)
- Cost per readmission: $13,000 (CMS penalty + treatment)
- Hypothetical model input: attribute 40% of readmissions to medication nonadherence, pending a defined readmission study.
- Smart bottle cost: $45 per device + $3/month connectivity
- Assumed intervention effect: adherence rises from 65% to 88%; this is not a demonstrated smart-bottle result.
- Program duration: 12 months
Steps:
- Calculate baseline readmissions attributable to non-adherence:
- Among 1,000 index discharges, the assumed 25% 30-day rate yields 250 readmissions within 30 days.
- Under the assumed 40% attribution, 100 is the product of the assumed 250 readmissions and assumed attribution; it is not an observed count.
- Baseline adherence-related cost: 100 × $13,000 = $1,300,000
- Calculate improved readmissions with smart bottles:
- Adherence rises from 65% to 88% (23 percentage points; 35.4% relative increase); nonadherence falls from 35% to 12% (65.7% relative reduction). A readmission effect must be independently estimated.
- Prevented non-adherence readmissions: 100 × 0.35 = 35 readmissions avoided
- Remaining adherence-related readmissions: 100 - 35 = 65 readmissions
- New adherence-related cost: 65 × $13,000 = $845,000
- Calculate program cost:
- Device cost: 1,000 × $45 = $45,000 (one-time)
- Connectivity: 1,000 × $3 × 12 = $36,000 (annual)
- Integration labor (FHIR API, EHR): $25,000 (one-time)
- Clinical monitoring staff: $80,000/year (nurse reviewing adherence data)
- Total Year 1 cost: $186,000
- Calculate net savings:
- Prevented readmission savings: $1,300,000 - $845,000 = $455,000
- Net savings Year 1: $455,000 - $186,000 = $269,000
- Modeled first-year ROI: $269,000/$186,000 ≈ 145%, conditional on validating the assumed avoided admissions.
- Calculate Medicare reimbursement potential:
- RPM code 99454 (device supply): 1,000 × $62/month × 12 = $744,000
- RPM code 99457 (first 20 min): 1,000 × $51/month × 12 = $612,000
- Total reimbursable: $1,356,000 (offsets costs and creates revenue stream)
Result: Under these assumptions, gross avoided admission costs are about 2.45 times program cost and net modeled savings about 1.45 times cost; payer reimbursement is a separate uncertain line item. Any modeled benefit depends on validating avoided admissions and separately accounting for treatment costs, CMS payment adjustments, device purchase, connectivity, integration and staff.
Key insight: Healthcare IoT economics depend on separately modeled treatment costs, payer adjustments, device and connectivity costs, integration, and staff; do not equate an avoided admission with an avoided CMS penalty.